U.S. House · 118th Congress · H.R. 4692
Increasing Prescription Drug Competition Act
To amend the Federal Food, Drug, and Cosmetic Act to prevent the use of patents, trade secrets, or other intellectual property to inhibit competition.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Elissa SlotkinD-MI-7
- Introduced
- July 17, 2023, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (0)
No member has cosponsored this bill.